Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Se-75-labeled bile acid analogs, new radiopharmaceuticals for investigating the enterohepatic circulation. [Rats]

Journal Article · · J. Nucl. Med.; (United States)
OSTI ID:6293023
Four selenium-labeled free bile acids and four selenium-labeled conjugated bile acids, labeled with Se-75 at the C-19, C-22, C-23, or C-24 position, have been synthesized and their absorption and excretion compared with that of (24-/sup 14/C)cholic acid, following both oral and intravenous administration. All but one of the compounds is absorbed and excreted in bile to a significant extent. One compound, SeHCAT, has been selected for particular study. It is quantitatively absorbed from the gut at the same rate as cholic acid, and both are excreted into the bile at the same rate. It remains almost entirely confined to the enterohepatic circulation (the gut, liver, and biliary tree) and excretion is exclusively fecal. Such a compound offers the possibility of a simple, novel, and aesthetically acceptalbe method investigating small-bowel disease.
Research Organization:
Univ. of Edinburgh, Scotland
OSTI ID:
6293023
Journal Information:
J. Nucl. Med.; (United States), Journal Name: J. Nucl. Med.; (United States) Vol. 22:8; ISSN JNMEA
Country of Publication:
United States
Language:
English

Similar Records

Se-75-labeled bile acid analogs, new radiopharmaceuticals for investigating the enterohepatic circulation
Journal Article · Sat Aug 01 00:00:00 EDT 1981 · J. Nucl. Med.; (United States) · OSTI ID:5367250

Enterohepatic circulation in man of a gamma-emitting bile-acid conjugate, 23-selena-25-homotaurocholic acid (SeHCAT)
Journal Article · Sun Jan 31 23:00:00 EST 1982 · J. Nucl. Med.; (United States) · OSTI ID:5635392

Enterohepatic circulation in man of a gamma-emitting bile-acid conjugate, 23-selena-25-homotaurocholic acid (SeHCAT)
Journal Article · Sun Jan 31 23:00:00 EST 1982 · J. Nucl. Med.; (United States) · OSTI ID:5478227